TEMPE, Ariz., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the 3rd Annual European Life Science CEO Forum, SIX Swiss Exchange, ConventionPoint, Selnaustrasse 30, CH-8021 Zurich, Switzerland on Thursday, February 11, 2010 at 3:15pm local time (GMT+1). Dana B. Shinbaum, Vice President, Business Development will provide an overview and discuss the Company’s current operating environment and business strategy.
